CRA-2059

Modify Date: 2025-08-26 19:17:26

CRA-2059 Structure
CRA-2059 structure
Common Name CRA-2059
CAS Number 256649-36-2 Molecular Weight 750.80
Density N/A Boiling Point N/A
Molecular Formula C34H46N12O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CRA-2059


CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].

 Names

Name CRA-2059

 CRA-2059 Biological Activity

Description CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].
Related Catalog
In Vitro Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1].
References

[1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.

[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.

 Chemical & Physical Properties

Molecular Formula C34H46N12O8
Molecular Weight 750.80
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

CRA-2059 suppliers

CRA-2059 price

Related Compounds: More...
1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
291538-79-9
CRA-026440 hydrochloride
847459-98-7
N-ethyl-4-[4-(3-fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]-6-methyl-N-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrimidin-2-amine
226948-11-4
CRA-026440
847460-34-8
(2R)-2-[[2-[(6-carbamoyl-1H-benzimidazol-2-yl)methyl]-3-methylbenzimidazole-5-carbonyl]amino]-3-phosphonopropanoic acid
263870-19-5
[6-[[6-[4-[4-(5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl)oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-3-hydroxy-2-methyloxan-4
120381-88-6
benzenesulfonic acid,1-[8-(2,4-dichlorophenyl)-2-methylquinolin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
694491-71-9
Ibrutinib (PCI-32765)
936563-96-1
2-(2-hydroxyphenyl)-1H-indole-5-carboximidamide
179748-10-8
tert-butyl N-[3-(2-bromo-1-hydroxyethyl)-4-fluorophenyl]carbamate
2229130-26-9
[1-(3,5-Difluoropyridin-4-yl)cyclopentyl]methanamine
2229435-88-3
[1-(3,4-dihydro-2H-1-benzopyran-3-yl)cyclopropyl]methanamine
2228244-26-4
2-(3aH-benzimidazol-2-yl)-3-hydroxy-5,5-dimethylcyclohex-2-en-1-one
57479-06-8
(1R)-1-(5-bromo-2-fluoropyridin-3-yl)-2,2,2-trifluoroethan-1-ol
2227829-60-7
tert-butyl 4-[1-(2-aminoethyl)cyclopropyl]-1H-imidazole-1-carboxylate
2229546-20-5
4-Methoxy-4-[(thiolan-2-yl)methyl]piperidine
2228244-36-6
2,2-Dimethyl-3-(2-methyl-5-nitrophenyl)propan-1-ol
2228277-58-3
2-Chloro-4-(1-ethynylcyclopropyl)-1,3-difluorobenzene
2229342-90-7
rac-4-[(1R,2R)-2-(aminomethyl)cyclopropyl]-5-bromo-2-methoxyphenol
2227884-96-8